HIRA to disclose screening details of drug-related applications next month

Published: 2004-02-24 06:57:00

Updated: 2004-02-24 06:57:00

The Health Insurance Review Agency said recently that from this March, all procedures involving approval or rejection of drug-related applications by the Diagnosis Screening Evaluation Committee will be opened to the public through internet homepages (www.hira.or.kr) and its monthly in-house maga...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK